Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

US Patent 9579407 · Granted Feb 28, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds2024
Heterocyclic compounds2022
Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancin2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Compounds for use in imaging, diagnosing and/or treatment of diseases of the cen2019
Heterocyclic compounds having cholesterol 24-hydroxylase activity2018
Nitrogenated heterocyclic compound2018
Heterocyclic compound2018
Compounds for use in imaging, diagnosing and/or treatment of diseases of the cen2017
Heterocyclic compound2017
Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating d2017
Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors2016